238 followers
RT @FerrandoRau: The Cost-Effectiveness Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature- PubMed - NCBI https…
RT @FerrandoRau: The Cost-Effectiveness Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature- PubMed - NCBI https…
RT @FerrandoRau: The Cost-Effectiveness Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature- PubMed - NCBI https…
RT @FerrandoRau: The Cost-Effectiveness Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature- PubMed - NCBI https…
The Cost-Effectiveness Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature- PubMed - NCBI https://t.co/iERGsc6TFX